Mackenzie Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,896
Closed -$288K 1679
2025
Q3
$288K Hold
24,896
﹤0.01% 1434
2025
Q2
$305K Hold
24,896
﹤0.01% 1392
2025
Q1
$357K Hold
24,896
﹤0.01% 1322
2024
Q4
$396K Hold
24,896
﹤0.01% 1269
2024
Q3
$598K Sell
24,896
-1,026
-4% -$23.4K ﹤0.01% 976
2024
Q2
$516K Buy
25,922
+8,775
+51% +$171K ﹤0.01% 1007
2024
Q1
$341K Buy
17,147
+987
+6% +$19.1K ﹤0.01% 1126
2023
Q4
$362K Hold
16,160
﹤0.01% 1095
2023
Q3
$325K Buy
16,160
+211
+1% +$4.78K ﹤0.01% 1115
2023
Q2
$406K Hold
15,949
﹤0.01% 1081
2023
Q1
$474K Buy
15,949
+2,524
+19% +$73.3K ﹤0.01% 1039
2022
Q4
$363K Buy
+13,425
New +$328K ﹤0.01% 1026
2022
Q3
Sell
-8,655
Closed -$237K 1439
2022
Q2
$237K Buy
+8,655
New +$249K ﹤0.01% 1207
2018
Q4
Sell
-30,100
Closed -$2.06M 1142
2018
Q3
$2.06M Buy
+30,100
New +$1.94M 0.01% 654

Other funds holding AVNS

Mackenzie Financial's AVNS Position: Q4 2025 in Review

Mackenzie Financial sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 24,896 shares — an estimated $288K sold.

Mackenzie Financial first reported a position in AVNS in Q3 2018 and held it in 14 quarters. The position peaked at $2.06M in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Mackenzie Financial reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Mackenzie Financial sold 24,896 Avanos Medical shares in Q4 2025, an estimated $288K.
  • Mackenzie Financial first reported a position in Avanos Medical in Q3 2018 and held it in 14 quarters.
  • Mackenzie Financial's Avanos Medical position peaked at $2.06M in Q3 2018.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.